Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 20 EP applications Emma Jane Hodge has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11785381

SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61K 31/341, A61K 31/40, A61K 31/437, A61K 31/4402, A61P 9/08, C07C 235/36, C07C 235/40, C07D 207/16, C07D 213/55, C07D 235/00, C07D 257/04, C07D 307/52
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790902

SUBSTITUTED AMINO BISPHENYL PENTANOIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61P 9/08, C07C 235/70
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12742957

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/4523, A61K 35/00, C07D 401/04, C07D 401/14, C07D 471/04, C07D 487/04, C07D 491/04, C07D 495/04, C07D 498/04, C07D 513/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742995

4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/519, A61P 35/00, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742994

NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/506, A61K 31/517, A61K 31/519, A61P 35/00, C07D 401/12, C07D 409/14, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772493

BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/4162, A61K 31/4188, A61P 9/12, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783308

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61K 31/4439, A61K 31/497, A61P 11/00, C07D 413/04, C07D 417/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12780535

CHOLINE SALT OF AN ANTI - INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND

IPC classification:
A61K 31/18, A61P 29/00, C07C 215/40, C07C 311/48
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12805775

PYRAZOLOPYRROLIDINE COMPOUNDS

IPC classification:
A61K 31/4162, A61K 31/4439, A61K 31/506, A61K 31/513, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783311

N-SUBSTITUTED HETEROCYCLYL CARBOXAMIDES

IPC classification:
A61K 31/415, A61K 31/4439, A61K 31/497, A61P 11/06
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13707037

SALTS OF AN IP RECEPTOR AGONIST

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705579

7,8- DIHYDROPYRIDO [3, 4 - B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705578

FUSED PYRROLES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705581

FUSED DIHYDROPYRIDO [2,3 -B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707437

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PAH AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705582

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP14155848

Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

IPC classification:
A61K 31/41, A61K 31/415, A61K 31/42, A61P 7/10, C07D 231/40, C07D 257/06, C07D 261/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13720079

CRYSTALLINE FORM OF A SUCCINATE SALT

IPC classification:
A61K 31/438, A61P 11/00, A61P 35/00, C07D 471/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11784638

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

IPC classification:
A61K 31/192, A61K 31/194, A61K 31/197, A61K 31/198, A61K 31/216, A61K 31/235, A61K 31/265, A61K 31/335, A61K 31/34, A61K 31/35, A61K 31/381, A61K 31/40, A61K 31/41, A61K 31/42, A61K 31/44, A61K 31/505, A61K 31/513, A61K 31/5375, A61K 31/55, A61K 45/06, A61P 13/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature